620 South 20th Street, NHB 104 — Birmingham, Alabama

620 South 20th Street, NHB 104 is a clinical research site located in Birmingham, Alabama, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

620 South 20th Street, NHB 104 has participated in 1 clinical trials.

Therapeutic areas: Asthma.

Sponsors: Boehringer Ingelheim.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 620 South 20th Street, NHB 104?

620 South 20th Street, NHB 104 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 620 South 20th Street, NHB 104 conducted?

620 South 20th Street, NHB 104 has 1 clinical trials on record. Their work covers Asthma.

Is 620 South 20th Street, NHB 104 accredited by Crixeo Health?

620 South 20th Street, NHB 104 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 620 South 20th Street, NHB 104?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.